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Abstract Mitochondria, microsomes and peroxisomes all ex-
press overt (cytosol-facing) carnitine palmitoyltransferase activ-
ity that is inhibitable by malonyl-CoA. The overt carnitine
palmitoyltransferase activity (CPTo) associated with the differ-
ent fractions was measured. Mitochondria accounted for 65% of
total cellular CPTo activity, with the microsomal and peroxi-
somal contributions accounting for the remaining 25% and 10%,
respectively. In parallel experiments, rat livers were perfused in
situ with medium containing dinitrophenyl (DNP)-etomoxir in
order to inhibit quantitatively and label covalently (with DNP-
etomoxiryl-CoA) the molecular species responsible for CPTo
activity in each of the membrane systems under near-physiolog-
ical conditions. In all three membrane fractions, a single protein
with an identical molecular mass of approximately 88 000 kDa
(p88) was labelled after DNP-etomoxir perfusion of the liver.
The abundance of labelled p88 was quantitatively related to the
respective specific activities of CPTo in each fraction. On
Western blots the same protein was immunoreactive with three
anti-peptide antibodies raised against linear epitopes of the
cytosolic N- and C-domains and of the inter-membrane space
loop (L) domain of the mitochondrial enzyme (L-CPT I).
However, the reaction of the microsomal protein with the anti-N
peptide antibody (raised against epitope Val-14^Lys-29 of CPT
I) was an order of magnitude stronger than expected from either
microsomal CPTo activity or its DNP-etomoxiryl-CoA label-
ling. This suggests that the N-terminal domain of the microsomal
protein differs from that in the mitochondrial or peroxisomal
protein. This conclusion was confirmed using antibody back-
titration experiments, in which the binding of anti-N and anti-C
antibodies by mitochondria and microsomes was quantified.
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1. Introduction
Long-chain fatty acids are converted to their acyl-coenzyme
A (CoA) esters within the cytosol. Delivery of the acyl moi-
eties to the mitochondrial matrix and endoplasmic reticular or
peroxisomal lumen necessitates conversion into the corre-
sponding acylcarnitines [1] by overt carnitine palmitoyltrans-
ferases (hereafter referred to generically as CPTo). Re-forma-
tion of acyl-CoA esters within the internal compartments of
these membrane systems (after transport of the acylcarnitines
through the respective membranes) is performed by a family
of latent CPTs [2,3]. All the CPTo activities of the di¡erent
cell membranes are inhibited by malonyl-CoA [4^6] in con-
trast to the latent CPT isoforms. Only the protein responsible
for the activity of the mitochondrial outer membrane (L-CPT
I) is well-characterised [7^9]. Results published in abstract
form only [10] have indicated that a peroxisomal protein of
Mr 88 000 resembling L-CPT I may be responsible for the
CPTo activity of these organelles, but these authors suggested
that it is immunologically distinct from L-CPT I. A micro-
somal protein of Mr 47 000 has previously been postulated to
represent the microsomal CPTo on the basis that, when mi-
crosomes are incubated with [3H]-etomoxir, CoA and ATP, a
protein of this molecular size was labelled most prominently
[11]. Similar observations were made by [12] who, however,
also observed that under these in vitro conditions at least one
other protein of Mr 87 000 was also prominently labelled.
More recently, it has been con¢rmed that microsomes express
a malonyl-CoA-sensitive overt CPT which has an apparent
molecular size of 300 kDa in detergent extracts of the mem-
branes [13].
In the present study we have measured CPTo activity in
mitochondrial, microsomal, peroxisomal and high-speed
supernatant fractions prepared from rat liver on a quantita-
tive basis. We have also quanti¢ed the relative expression of
proteins that bind dinitrophenyl (DNP)-etomoxiryl-CoA (a 2-
oxirane carboxylate irreversible inhibitor of hepatic CPT I
[14]), in each of these fractions in the intact isolated liver
perfused with DNP-etomoxir.
2. Materials and methods
2.1. Animals
These were female Wistar rats (200^230 g) maintained on a labo-
ratory chow diet [15] and starved for 24 h prior to being used, 2 h into
the light phase of a 12 h light-12 h dark regime.
2.2. Preparation of subcellular fractions
Livers were homogenised in an ice-cold medium containing 250
mM sucrose, 10 mM Tris, 1 mM EGTA (pH 7.4) and a cocktail of
protease inhibitors (Complete, Boehringer) designed to inhibit a wide
spectrum of mammalian cell proteases. Two protocols were used de-
pending on whether quantitative recovery of the fractions was re-
quired (protocol 1) or whether highly pure but non-quantitative prep-
arations of mitochondria and microsomes were required (protocol 2).
In protocol 1, after low-speed centrifugation of the homogenate
(500Ug for 10 min) to remove debris, the supernatant was centrifuged
for 10 min at 5800Ug to obtain a mitochondrial pellet. Preliminary
experiments indicated that, at a centrifugal force of 5800Ug, s 95%
of mitochondria were sedimented, but that 6 8% of microsomes were
lost from the supernatant. Microsomal pellets were obtained from the
5800Ug supernatants by centrifugation at 100 000Ug for 60 min. As
expected, most of the peroxisomes (s 90%) were sedimented with the
crude mitochondrial pellet. Therefore, routinely, puri¢ed peroxisomes
were prepared from this mitochondrial fraction by gradient centrifu-
FEBS 21648 5-3-99
0014-5793/99/$20.00 ß 1999 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 9 ) 0 0 1 7 9 - 9
*Corresponding author. Fax: (44) (1292) 674059.
E-mail: zammitv@hri.sari.ac.uk
FEBS 21648 FEBS Letters 446 (1999) 69^74
gation on a Nycodenz gradient, as described previously [16]. Samples
of all the fractions were retained for measurement of marker enzyme
activities in order to quantify the recovery of the individual membrane
populations from the liver and assess cross-contamination.
Protocol 2 was designed to obtain non-quantitative recoveries of
highly pure mitochondria and microsomes, in addition to Nycodenz-
puri¢ed peroxisomes. A crude mitochondrial pellet was obtained by
centrifugation of the 500Ug supernatant at 12 000Ug for 20 min.
One-half of this mitochondrial fraction was subjected to centrifuga-
tion on a 33% Percoll self-forming gradient to obtain highly pure
mitochondria, as described previously [17,18]. The other half was
used to prepare Nycodenz-puri¢ed peroxisomes, as described above.
Pure microsomes were obtained by centrifugation of the 12 000Ug
supernatants at 100 000Ug for 60 min.
2.3. Measurement of enzyme activities
The following enzyme activities were measured as described previ-
ously [8,18,19]: cytochrome c oxidase (mitochondria), NADPH-cyto-
chrome c oxidoreductase (microsomes), uricase (peroxisomes) and
lactate dehydrogenase (cytosol). CPTo activities were measured using
either an optimal concentration of palmitoyl-CoA (135 WM in the
presence of 1% albumin) to obtain maximal activities, or 35 WM
palmitoyl-CoA in the presence or absence of 100 WM malonyl-CoA,
as described previously [15].
2.4. Identi¢cation of proteins that bind DNP-etomoxiryl-CoA in intact
rat liver
Quantitative labelling of DNP-etomoxiryl-CoA-binding proteins
was performed in the intact liver prior to preparation of the various
subcellular fractions. Animals were anaesthetised with pentobarbitone
(60 mg/kg) and their livers (weighing 6^8 g) were perfused in situ for
30 min with 250 ml of oxygenated (95% O2 :5% CO2) recirculating
Krebs-Henseleit medium [20] containing 2.5 Wmol DNP-etomoxir, at
37‡. At the end of the perfusion, the liver subcellular fractions were
prepared using protocol 2, described above. Liver perfusion with
DNP-etomoxir (which is converted into the e¡ective inhibitory species
DNP-etomoxiryl-CoA within the cell) resulted in s 90% inhibition of
overt CPTO activity in all three membranous fractions.
2.5. Back-titration ELISA determination of antibody binding by intact
microsomes and mitochondria
This was performed as described previously [8] except that multi-
well plates were treated with 4% bovine albumin in phosphate-bu¡-
ered saline containing 0.1% Tween-20 for 1 h at 20‡C to block non-
speci¢c sites before applying the samples containing the primary anti-
body (anti-N or anti-C). Freshly prepared Percoll gradient-puri¢ed
intact mitochondria [18] and microsomes sedimented from 12 000Ug
supernatants (see protocol 2, above) were used. They were incubated,
at the protein concentrations indicated, for 16 h at 0‡C with anti-N or
anti-C antibodies in a total volume of 220 Wl. After sedimentation of
the membranes, the amounts of antibodies remaining in solution were
quanti¢ed by ELISA using donkey anti-sheep secondary antibody to
detect the amounts of primary antibody that could be bound by an
excess (160 ng) of the respective peptide coated on to the multi-well
plates. The total binding capacities of the amounts of antibodies
added to the incubations were previously determined to be 50 pmol
and 80 pmol of peptides N and C, respectively. In preliminary experi-
ments these amounts of antibodies were shown to reside on the linear
portions of their respective titre curves. Binding of the antibodies to
mitochondria or microsomes could be speci¢cally and completely dis-
placed by the respective peptides against which they were raised.
2.6. Preparation of samples for SDS-gel electrophoresis and Western
blotting
The proteins in aliquots of subcellular fractions were precipitated
with a ten-fold excess of ice-cold acetone, and the pellets washed with
cold 90% acetone. The ¢nal pellets were solubilised in a medium
containing 62 mM Tris-HCl, 69 mM SDS, 8 M urea, 6 mM dithio-
threitol (pH 6.8). The component proteins were separated on 8%
polyacrylamide gels and electrotransferred onto nitrocellulose. The
resulting blots were probed with rabbit anti-DNP and sheep anti-
CPT I peptide antibodies raised against linear epitopes N, L and C
of L-CPT I (described in [8]). Appropriate secondary antibodies (anti-
sheep or anti-rabbit IgG) conjugated to alkaline phosphatase were
used and visualised by using 5-bromo-1-chloro-3-indolyl phosphate
(BCIP) and nitro blue tetrazolium (NBT) as substrate and chromo-
phore, respectively. The intensity of the resulting bands was quanti¢ed
densitometrically (Imagequant, Molecular Dynamics).
2.7. Materials
Nycodenz and Percoll centrifugation media and general biochemi-
cals were from Sigma-Aldrich Ltd (Poole, UK). Complete protease
inhibitor tablets were from Boehringer Mannheim (Lewes, UK). BCIP
and NBT were from Promega UK (Southampton, UK). DNP-eto-
moxir was from Projekt-Entwicklung GmbH (Allensbach, Germany).
Rabbit anti-DNP IgG was from Molecular Probes (Cambridge Bio-
science, UK).
3. Results
Mitochondria and microsomes accounted for 65% and 25%
of total hepatic CPTo activity, respectively. These estimates
are similar to those made by [21] after quantitative prepara-
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Table 1
Quanti¢cation of CPTo activity (measured at 37‡C) and total protein (per g wet weight of liver) in the di¡erent subcellular fractions obtained
from 24 h starved rat livers using protocol 1 (Section 2)
Fraction Mitochondria Microsomes Peroxisomes Soluble
CPTo activity (Wmol/min) 0.40 þ 0.06 0.15 þ 0.04 0.07 þ 0.03 6 0.01
Total protein (mg) 25.1 þ 2.5 22.8 þ 1.9 2.15 þ 1.0 49.8 þ 3.1
Values are means ( þ S.E.M.) for three liver fractionations, and have been corrected for cross-contamination of fractions as determined by marker
enzyme activities.
Table 2
Speci¢c activities of CPTo and marker enzymes, and of the expression of DNP-etomoxiryl-CoA-binding protein (88 kDa) in subcellular frac-
tions prepared from liver of rats starved for 24 h using protocol 2 (Section 2)
Fraction Mitochondria Microsomes Peroxisomes Soluble
CPTo activity (nmol/min) 18.6 þ 4.9 8.1 þ 3.3 32.5 þ 2.7 6 0.01
DNP-etomoxir binding (arbitrary units) 1.0 0.45 þ 0.07 1.34 þ 0.30 6 0.01
Cytochrome c oxidase (Wmol/min) 2.1 þ 0.3 0.2 þ 0.1 0.3 þ 0.1 6 0.01
NADPH-cytochrome c oxidoreductase (nmol/min) 10.1 þ 1.1 100.1 þ 9.0 8.9 þ 2.3 6 0.01
Uricase (nmol/min) 20.8 þ 3.8 16.3 þ 3.3 247.5 þ 9.0 6 0.01
Enzyme activities were measured at 37‡C. For enzyme activities, values (for four separate fractionations) are expressed per mg protein of the
relevant fraction. Expression of DNP-etomoxiryl-CoA- binding protein was measured by densitometric analysis of Western blots (probed with anti-
DNP antibody) prepared after SDS-polyacrylamide electrophoresis of aliquots (100 Wg protein) of the three fractions. The DNP-etomoxiryl-CoA
binding to p88 derived from the mitochondrial fraction has been arbitrarily set at 1.0 and binding to the protein within puri¢ed microsomal and
peroxisomal fractions isolated from the same liver are expressed relative to this value.
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tion of these three membrane fractions from starved rat liver.
No CPT activity could be detected in the high-speed super-
natant fraction Table 1. Speci¢c activities of CPTo (corrected
for cross-contamination) and marker enzyme activities for the
di¡erent fractions obtained by protocol 2 are given in Table 2.
The marker enzyme data show that the fractions were sub-
stantially pure. Therefore, the CPTo and Western blot data
presented below could not have been a¡ected by any major
cross-contamination. The highest CPTo speci¢c activity (ex-
pressed per mg protein) was observed in the peroxisomal frac-
tion, whereas microsomes showed the lowest speci¢c activity
(Table 2).
3.1. DNP-etomoxiryl-CoA labelling of cell proteins
In order to identify and quantify the relative amounts of
CPTo proteins expressed in each fraction, we labelled them in
the intact liver in situ prior to the quantitative preparation of
subcellular fractions using protocol 2. This ensured that in
vitro artefacts due to non-speci¢c binding of 2-oxirane car-
boxylates, when incubated in large molar excess over the
amount of CPTo in isolated microsomes, were avoided. Using
the DNP-etomoxir-perfused liver we were able to optimise the
speci¢c labelling of p88 in all the three cell fractions prior to
homogenisation of the liver under identical conditions to
those used in parallel experiments in which CPTo activity
was quanti¢ed. A minimal quantity of DNP-etomoxir, su⁄-
cient to inhibit 90^95% of the activities in all three membrane
fractions was used. Preliminary experiments established that
recirculating perfusion of rat liver (6^8 g) with 250 ml of
medium containing 2.5 Wmol of DNP-etomoxir for 30 min
at 37‡C was su⁄cient to achieve this.
DNP-etomoxiryl-CoA bound to proteins in each fraction
was quanti¢ed by SDS-polyacrylamide gel electrophoresis fol-
lowed by electroblotting onto nitrocellulose and probing with
anti-DNP antibody. A representative Western blot is shown in
Fig. 1. In all three membrane fractions only a protein that
migrated with an apparent mass of 88 kDa (p88) was repro-
ducibly labelled by DNP-etomoxiryl-CoA (Fig. 1). A smaller
protein (Mr 47 000) was sometimes labelled in peroxisomes
but its extent of labelling was very variable (and sometimes
absent) and not proportional to peroxisomal CPTo activity.
Moreover, by contrast with p88, it was not detected by any of
the three anti-peptide antibodies raised against di¡erent re-
gions of the mitochondrial CPT I (see below). Consequently,
this smaller band was considered to have resulted from non-
speci¢c labelling by the highly reactive DNP-etomoxir mole-
cule. Non-speci¢c labelling was much more marked when liv-
ers were perfused with higher amounts of DNP-etomoxir.
While for mitochondria and peroxisomes the labelling of
the 88 kDa protein was as expected from previous studies
[7,10,22,23], the result for microsomes was surprising. This
in view of the previous suggestion [11] that CPTo activity in
these membranes is associated with a molecular species of Mr
47 000. Evidence that the labelled p88 represents the micro-
somal overt CPT stems from the observations that (i) the
quantitative inhibition of CPTo in all the fractions was
achieved under conditions which also labelled this protein
quantitatively, and (ii) that the capacity for speci¢c binding
of DNP-etomoxiryl-CoA by the di¡erent membranous frac-
tions (expressed per mg protein) was positively related to the
respective speci¢c activities of CPTo (Table 2). Thus, peroxi-
somes showed the highest values (per mg protein) for both
DNP-etomoxiryl-CoA binding and overt CPTo activity,
whereas microsomes had the lowest values for both parame-
ters, with mitochondria having intermediate values.
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Fig. 1. Detection of DNP-etomoxiryl-CoA-labelled p88 in mitochon-
dria, microsomes and peroxisomes prepared from rat livers previ-
ously perfused with DNP-etomoxir. Subcellular fractions were pre-
pared from DNP-etomoxir perfused isolated rat livers, using
protocol 2 Section 2. Lane 1: molecular weight markers; 2: 500Ug
supernatant; 3: mitochondria; 4: microsomes; 5: 100 000Ug super-
natant; and 6: peroxisomes. In the experiment shown, a second per-
oxisomal protein of MrV47 000 was also labelled. However, label-
ling of this smaller protein was not always observed and it was not
proportional to peroxisomal CPTo activity. In addition, none of the
three anti-peptide antibodies detected a protein of this size on im-
munoblots. When detected, it was also present in the mitochondrial
fraction due to minor contamination by peroxisomes (see Table 2).
Fig. 2. Immunoreactivity of CPTo in (1) mitochondria, (2) micro-
somes and (3) peroxisomes with three anti-peptide antibodies raised
against linear epitopes of liver mitochondrial CPT I, compared to
DNP-etomoxiryl-CoA binding to p88 derived from the same frac-
tions. Subcellular fractions were prepared from DNP-etomoxir-per-
fused livers as described in the text and 100 Wg protein of each was
subjected to SDS-PAGE, followed by probing with (a) anti-DNP,
(b) anti-L, (c) anti-C, and (d) anti-N peptide antibodies. The West-
ern blots shown are representative of four similar blots on separate
preparations.
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3.2. Immunological cross-reaction with antibodies raised
against linear epitopes of mitochondrial CPT I
Blots of the constituent proteins of the three membrane
fractions obtained after separation by SDS-PAGE were
probed with the three antibodies (anti-N, -L and -C) raised
against di¡erent regions of the mitochondrial CPT I protein
described previously [8].
All three antibodies detected a protein of identical size
(MrV88 000) in mitochondria, microsomes and peroxisomes
(Fig. 2). This suggested that in all three membrane fractions,
CPTo activity is associated with the same or highly similar
molecular species. However, there was one important di¡er-
ence between the microsomal protein and that in the other
two membranous fractions. It can be seen from Fig. 2 that,
for equivalent amounts of total membrane protein, reaction of
p88 with all the antibodies except anti-N was highest for per-
oxisomes and lowest for microsomes. By marked contrast,
reaction with anti-N antibody was by far the highest for the
microsomal protein. Thus, as expected from our previous
studies [8] the anti-N antibody gave a very weak reaction
with L-CPT I in the mitochondrial fraction. This was also
the case for the peroxisomal protein. However, the signal
obtained with the microsomal protein was much stronger
than would have been anticipated from either the relatively
low expression of CPTo activity or of the p88 labelled by
DNP-etomoxiryl-CoA. Quanti¢cation of the bands was per-
formed by densitometry and the results from four separate
experiments are presented in Fig. 3, together with those for
the relative CPTo activities in each fraction. For each param-
eter the speci¢c activity or antibody binding (expressed per mg
protein), obtained for the mitochondrial fraction has been set
at unity. It can be seen (Fig. 3) that, in all three membrane
fractions, whereas the relative intensities of interaction of anti
N- and anti-C peptide antibodies were proportional to CPTo
activity and expression of the p88 DNP-etomoxiryl-CoA
binding protein, the intensity of reaction of the microsomal
CPTo with anti-N antibody was an order of magnitude higher
than expected from either of these parameters. This suggests
that when the proteins are partially refolded on nitrocellulose,
the N-epitope (Val-14^Lys-29) of the microsomal CPTo is
much more readily available for interaction with the anti-N
antibody than that of p88 separated from either the mitochon-
drial or peroxisomal fractions.
3.3. Binding of anti-N and anti-C antibodies to native CPTo in
microsomes and mitochondria
In order to test whether this inference is borne out for the
native proteins we performed experiments to determine
whether we could detect di¡erential binding of anti-N anti-
bodies by mitochondria and microsomes. After incubation of
mitochondria or microsomes with anti-N or anti-C antibodies,
the amounts of antibody remaining in solution after sedimen-
tation of the membranes were quanti¢ed by back-titration
ELISA. As seen in Fig. 4a, microsomal membranes bound
FEBS 21648 5-3-99
Fig. 4. Binding of anti-N and anti-C antibodies by intact micro-
somes and rat liver mitochondria. Microsomes (a) or mitochondria
(b) were incubated, at the protein concentrations shown, for 16 h at
0‡C with anti-N (b) or anti-C (a) antibodies in a total volume of
220 Wl. After sedimentation of the membranes, the amounts of anti-
bodies remaining in solution were quanti¢ed by ELISA using don-
key anti-sheep secondary antibody to detect the amounts of primary
antibody that could be bound by an excess (160 ng) of the respec-
tive peptide coated on to the multi-well plates. Values are means
( þ S.E.M.) for three separate determinations. The initial binding ca-
pacities of the antibodies in the incubations (100%) were equivalent
to 50 pmol and 80 pmol of peptides N and C, respectively. In pre-
liminary experiments these amounts of antibodies were shown to re-
side on the linear portions of their respective titration curves. Anti-
body speci¢city was ascertained by the abolition of binding in the
presence of excess peptide (not shown). Values are means
( þ S.E.M.) for determinations on three separate subcellular fraction-
ations. Where error bars do not show, they lie within the symbols.
Fig. 3. Quantitative comparison of the immunoreactivity of p88
with anti-CPT I peptide antibodies and the CPTo speci¢c activity
and DNP-etomoxiryl-CoA binding in each of the three subcellular
fractions. Data for the degree of DNP-etomoxiryl-CoA labelling of
p88 obtained as described in Fig. 2 were quanti¢ed using densitome-
try. They are compared with values of the CPTo activity observed
in each fraction and the amount of p88 immunoreactive with each
of the anti-CPT I peptide antibodies. Expression of the data ob-
tained from four separate experiments was standardised by setting
the values of each parameter for the mitochondrial fraction at unity.
Those for the other fractions are expressed (means þ S.E.M.) relative
to them. Key to bars: mitochondria (empty), microsomes (solid),
peroxisomes (stippled).
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and removed from solution both anti-N and anti-C antibodies
e⁄ciently over the same range of membrane protein concen-
trations. By contrast, and in con¢rmation of our previous
data [8], mitochondria bound anti-C antibody e⁄ciently but
reacted very poorly with anti-N (Fig. 4b). These data indicate
that even when the mitochondrial and microsomal CPTo pro-
teins are in the native conformations, the N-epitope (Val-14^
Lys-29) is much more highly exposed for interaction with the
anti-N antibody in the microsomal CPTo than in the mito-
chondrial protein.
4. Discussion
CPTo activity in microsomes and peroxisomes is accompa-
nied by the presence of only one molecular species (Mr 88 000)
that reproducibly binds DNP-etomoxiryl-CoA. Several lines
of evidence suggest that this protein is very similar, if not
identical, to the mitochondrial outer membrane CPTo, i.e.
L-CPT I [7]. Thus (i) their sizes appear to be identical after
separation by SDS-polyacrylamide gel electrophoresis, (ii)
their relative speci¢c expression in the three membrane frac-
tions varies in parallel with the speci¢c activity of CPTo, and
(iii) anti-peptide antibodies raised against three di¡erent linear
epitopes of mitochondrial CPT I cross-react with the same
protein in all three fractions. A similarity between the molec-
ular sizes of mitochondrial and peroxisomal CPTo was ob-
served previously [10]. It is also noteworthy that in previous
work in which microsomes were incubated with [3H]etomoxir,
ATP and CoA [12] although the most highly labelled protein
was of Mr 54 000, very substantial labelling of a protein of Mr
88 000 also occurred. Moreover, contrary to the Mr 54 000
protein, the labelling of the Mr 88 000 species could be atten-
uated by prior incubation of the microsomes with malonyl-
CoA, suggesting that, in spite of its lower degree of labelling
under in vitro conditions, this 88 000 Da protein represented
microsomal CPTo. However, this possibility was discounted
by those authors because of their contention that it was a
regulatory subunit of CPTo (a theory which has since been
shown to be untenable, at least for mitochondrial CPT I, see
[7,24]). In view of the above data, we suggest that CPTo in all
three membrane fractions is associated with a protein of ap-
proximate Mr = 88 000 and that the current views about the
identity of CPTo in mitochondria, microsomes and peroxi-
somes need to be re-evaluated.
The di¡erential reactivity of the Val-14^Lys-29 epitope with
the anti-N antibody was observed both in Western blots and
when intact microsomes and mitochondria were used, thus
excluding the possibility that di¡erential antibody binding
may have resulted from artefacts arising during electrophoret-
ic separation and electrotransfer of the proteins onto nitro-
cellulose. We conclude, therefore, that the epitope against
which the antibody was raised is sterically masked within
the N-terminal domain of the mitochondrial (and peroxiso-
mal) CPTo, but not of microsomal CPTo. That the epitope of
the mitochondrial protein is fully capable of interacting with
the antibody when unmasked was evidenced by our previous
observation [8] that the proteolytic cleavage of the extreme N-
terminus of the protein markedly increases (by 10-fold) its
immunoreactivity with anti-N antibody.
Interaction between the N-terminal and C-terminal do-
mains is crucial in determining the malonyl-CoA sensitivity
of mitochondrial CPT I [8,25]. It is plausible that the molec-
ular mechanism that results in the masking of the Lys-14^Val-
29 epitope in the mitochondrial protein may be related to the
two-fold higher sensitivity of the microsomal enzyme to ma-
lonyl-CoA inhibition [21]. The results of Western blots probed
with anti-N antibody indicate that no such di¡erences occur
between the N-terminal domains of mitochondrial and perox-
isomal CPTo. In this respect, it is noteworthy that the malon-
yl-CoA sensitivity of the mitochondrial and peroxisomal
CPTo activities are identical, as is their response to 48 h
starvation of the donor animals [26].
The suggestion that CPTo in di¡erent cell membrane sys-
tems could be due to the same, or very similar, molecular
species has parallels. Thus, long-chain acyl-CoA synthase,
which catalyses the formation of the acyl-CoA esters utilised
by CPTo, exists in all three membrane systems as an appar-
ently identical molecular species [27]. Similarly, Bcl-2 the anti-
apoptotic protein which may interact with CPT I [28] is lo-
cated not only in the mitochondrial outer membrane, but also
in the endoplasmic reticular and nuclear membranes [29,30].
Targeting of such widely distributed proteins to di¡erent cy-
tosol-facing membranes may involve the use of multiple [31]
or hierarchical [32,33] targeting sequences, co-translational
import directly from cytosolic polysomes [34] or the use of
splice variant mRNA species that di¡er only in their 5P-un-
translated regions but which are important in directing site-
speci¢c translation (e.g. for long-chain acyl-CoA synthetase
[35]). Whether the molecular mechanism that gives rise to
the distinctive N-terminal domain conformation of the micro-
somal CPTo also a¡ects the membrane targeting speci¢city of
the nascent protein will require further study.
Finally, the binding of both anti-N and anti-C antibodies
by intact microsomes also con¢rms that the topology of CPT
in the endoplasmic reticular membrane is the same as that in
the outer membrane of mitochondria [8] namely, a polytopic
one which results in both the N- and C-domains being ex-
posed on the cytosolic aspect of the membrane.
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